-
Document de presse | 2024.10.24
Depression: dysfunction of neurons in the amygdala may be behind negative perceptions of the environment
One of the characteristics of depression is a tendency to perceive sensory stimuli and everyday situations in an excessively negative way. But the mechanisms underpinning this "negativity bias," which can fuel the development of depressive symptoms, had previously remained largely unknown. To shed light on the question, scientists from the Institut Pasteur and the CNRS, in collaboration with...
-
Document de presse | 2024.10.24
Evaluating the link between chemicals and declining insect populations
Using a library of more than 1,000 agrochemicals, scientists saw significant changes in behaviour and long-term survival of different insect populations.Summary Employing a library of more than 1,000 chemicals, EMBL scientists, in collaboration with the Institut Pasteur, Heidelberg University Hospital and George Washington University, investigated how agrochemicals affect insect populations.The...
-
Document de presse | 2024.11.08
The new face of “MAKE IT ICONIC. Choose France”, Professor Yasmine Belkaid embodies French boldness in the Government's international campaign
Professor Yasmine Belkaid, immunologist and President of the Institut Pasteur, has joined the international attractiveness campaign “MAKE IT ICONIC. Choose France*”, which aims to promote France's boldness and spirit of innovation, by showcasing the country's research, expertise, know-how and economic strength.A joint project between the French Ministry for Europe and Foreign Affairs’ Press and...
-
Document de presse | 2024.11.12
A*STAR IDL and Institut Pasteur unite their expertise to boost infectious diseases research across the asia-pacific region
Singapore’s Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) and France’s Institut Pasteur have signed a Memorandum of Understanding (MoU) to address the urgent health threats posed by the rise of tropical infectious diseases (ID) in the Asia-Pacific region. Together, this partnership would enable both parties to co-develop innovative technologies with...
-
Document de presse | 2025.01.31
IRD, DNDi, Institut Pasteur de Guinée and the Institut Pasteur welcome the WHO validation for the elimination of sleeping sickness in Guinea
Guinea celebrates today the elimination of sleeping sickness (also known as human African trypanosomiasis or HAT) as a public health problem.Despite health crises such as the 2013-2015 Ebola epidemic and the SARS-Cov2 pandemic, combined medical and vector control strategies have enabled Guinea to reach the threshold of eliminating sleeping sickness as a public health problem (less than one case...
-
Document de presse | 2025.01.16
Institut Pasteur decides to leave X
The Institut Pasteur, a research organization which for more than 130 years has been committed to tackling infectious diseases, sharing knowledge and defending science, has decided to leave X because of several serious abuses observed on the platform since its takeover by Elon Musk. We are suspending our day-to-day activities on the platform immediately and will encourage our subscribers to...
-
Document de presse | 2024.12.06
From Yemen to Mayotte, the spread of a highly drug-resistant cholera strain
Scientists from the National Reference Center for Vibrios and Cholera at the Institut Pasteur, in collaboration with the Centre hospitalier de Mayotte, have revealed the spread of a highly drug-resistant cholera strain. The study was published on December 12, 2024 in the New England Journal of Medicine. Cholera is an infectious diarrheal disease caused by certain bacteria of the species Vibrio...
-
Document de presse | 2024.11.21
Phages, towards a targeted alternative to antibiotics
With the rapid development of antibiotics in the 1930s, phage therapy – using viruses known as bacteriophages or phages to tackle bacterial infections – fell into oblivion. But as the current rise in antibiotic resistance is making it increasingly difficult to treat bacterial infections, phage therapy is once again sparking interest among physicians and scientists – although it remains complex in...
-
Vidéo | 2025.02.04
What is bronchiolitis?
Bronchiolitis, a respiratory infection affecting infants, is caused in 60-80% of cases by the respiratory syncytial virus (RSV). It begins as a cold with moderate fever, but can lead to coughing, difficulty breathing, wheezing and eating disorders. Marie-Anne Rameix-Welti, respiratory virus expert at the Institut Pasteur, shares essential advice on protecting infants from bronchiolitis.Prevention...
-
News | 2025.02.10
Women scientists: inspiring faces of research at the Institut Pasteur
The International Day of Women and Girls in Science 2025 is an opportunity to shine the spotlight on committed and talented women researchers. In addition to their scientific work, these Institut Pasteur scientists, also called Pasteurians, are creative person involved in scientific outreach who work to make science accessible to all (all videos below in French).
